prnewswire.comCoya Therapeutics Announces FDA Acceptance of Investigational New Drug (IND) Application for COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)1 day ago
benzinga.comInsider Decision: Nimrata Hunt Exercises Options At IDEXX Laboratories For $509K12 days ago
benzinga.com$1000 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth This Much Today13 days ago
benzinga.comOptions Exercise Activity Initiated By Jonathan Jay Mazelsky At IDEXX Laboratories Worth $10K13 days ago
benzinga.comWitnessing An Insider Decision, Andrew Emerson Exercises Options Valued At $943K At IDEXX Laboratories14 days ago
prnewswire.comBDC Laboratories Partners with Newly Launched Dilawri Cardiovascular Institute to Advance Clinically Relevant Cardiovascular Device Testing19 days ago
CashuDr. Reddy's Laboratories Partners with Coya Therapeutics to Innovate ALS Treatment Optionsabout 18 hours ago
CashuDr. Reddy's Laboratories: Driving Biopharmaceutical Innovation Through R&D and Strategic Collaborations9 days ago
CashuDr. Reddy's Laboratories and IDEXX Insider Transactions Signal Executive Confidence in Growth10 days ago